1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 1: 
Epidemiologic and clinical characteristics
CharacteristicValue
Age
    Median (range) (yr)54 (19–66)
Subgroup (No. of patients) (%)
    0–191 (4.1)
    20–396 (25.0)
    40–5911 (45.8)
    ≥606 (25.0)
Male sex (No.) (%)24 (100)
Neurologic symptoms (No. of patients) (%)
    Headache8 (33.3)
    Epilepsy7 (29.1)
    Focal neurologic signs6 (25.0)
    Paresis5 (20.8)
    Paresthesia4 (16.6)
    Plegia2 (8.3)
    Dysarthria2 (8.3)
    Mental confusion2 (8.3)
    Head lump2 (8.3)
    Diplopia1 (4.1)
    Chorea1 (4.1)
    Vertigo1 (4.1)
    Absence of neurologic symptom2 (8.3)